Association between pretreatment haemoglobin levels and morphometric characteristics of the tumour, response to neoadjuvant treatment and long-term outcomes in patients with locall...

por Khan, A A, Klonizakis, M, Shabaan, A, Glynne-Jones, R
Publicado 2013

A phase II study to determine the ability of gefitinib to reverse fluoropyrimidine resistance in metastatic colorectal cancer (the INFORM study)

por Stebbing, J, Harrison, M, Glynne-Jones, R, Bridgewater, J, Propper, D
Publicado 2008

A phase I/II study of irinotecan when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group Study

por Glynne-Jones, R, Falk, S, Maughan, T S, Meadows, H M, Sebag-Montefiore, D
Publicado 2007

Neoadjuvant chemotherapy prior to preoperative chemoradiation or radiation in rectal cancer: should we be more cautious?

por Glynne-Jones, R, Grainger, J, Harrison, M, Ostler, P, Makris, A
Publicado 2006

A phase I/II study of oxaliplatin when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group (CCOG) st...

por Sebag-Montefiore, D, Glynne-Jones, R, Falk, S, Meadows, H M, Maughan, T
Publicado 2005

The effect of surgically induced ischaemia on gene expression in a colorectal cancer xenograft model

por Atkin, G, Daley, F M, Bourne, S, Glynne-Jones, R, Northover, J, Wilson, G D
Publicado 2006

The impact of surgically induced ischaemia on protein levels in patients undergoing rectal cancer surgery

por Atkin, G K, Daley, F M, Bourne, S, Glynne-Jones, R, Northover, J M A, Wilson, G D
Publicado 2006

Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I)

por Northover, J, Glynne-Jones, R, Sebag-Montefiore, D, James, R, Meadows, H, Wan, S, Jitlal, M, Ledermann, J
Publicado 2010

Initial Results from the Royal College of Radiologists' UK National Audit of Anal Cancer Radiotherapy 2015

por Muirhead, R., Drinkwater, K., O'Cathail, S.M., Adams, R., Glynne-Jones, R., Harrison, M., Hawkins, M.A., Sebag-Montefiore, D., Gilbert, D.C.
Publicado 2017

Hypoxia-inducible factor-1α and -2α are expressed in most rectal cancers but only hypoxia-inducible factor-1α is associated with prognosis

por Rasheed, S, Harris, A L, Tekkis, P P, Turley, H, Silver, A, McDonald, P J, Talbot, I C, Glynne-Jones, R, Northover, J M A, Guenther, T
Publicado 2009

Hypoxia-inducible factor-1α and -2α are expressed in most rectal cancers but only hypoxia-inducible factor-1α is associated with prognosis

por Rasheed, S, Harris, A L, Tekkis, P P, Turley, H, Silver, A, McDonald, P J, Talbot, I C, Glynne-Jones, R, Northover, J M A, Guenther, T
Publicado 2009

BACCHUS: A randomised non-comparative phase II study of neoadjuvant chemotherapy (NACT) in patients with locally advanced rectal cancer (LARC)

por Glynne-Jones, R., Hall, M.R., Lopes, A., Pearce, S., Goh, V., Bosompem, S., Bridgewater, J., Chau, I., Wasan, H., Moran, B., Melcher, L., West, N.P., Quirke, P., Wong, W.-L., Beare, S., Hava, N., Duggan, M., Harrison, M.
Publicado 2018

International expert consensus statement regarding radiotherapy treatment options for rectal cancer during the COVID 19 pandemic()

por Marijnen, C.A.M., Peters, F.P., Rödel, C., Bujko, K., Haustermans, K., Fokas, E., Glynne-Jones, R., Valentini, V., Spindler, K-L.G., Guren, M.G., Maingon, Philippe, Calvo, F.A., Pares, O., Glimelius, B., Sebag-Montefiore, D.
Publicado 2020

Bevacizumab and Combination Chemotherapy in rectal cancer Until Surgery (BACCHUS): a phase II, multicentre, open-label, randomised study of neoadjuvant chemotherapy alone in patien...

por Glynne-Jones, R., Hava, N., Goh, V., Bosompem, S., Bridgewater, J., Chau, I., Gaya, A., Wasan, H., Moran, B., Melcher, L., MacDonald, A., Osborne, M., Beare, S., Jitlal, M., Lopes, A., Hall, M., West, N., Quirke, P., Wong, Wai-Lup, Harrison, M.
Publicado 2015

First-line trifluridine/tipiracil + bevacizumab in patients with unresectable metastatic colorectal cancer: final survival analysis in the TASCO1 study

por Van Cutsem, E., Danielewicz, I., Saunders, M. P., Pfeiffer, P., Argilés, G., Borg, C., Glynne-Jones, R., Punt, C. J. A., Van de Wouw, A. J., Fedyanin, M., Stroyakovskiy, D., Kroening, H., Garcia-Alfonso, P., Wasan, H., Falcone, A., Fougeray, R., Egorov, A., Amellal, N., Moiseyenko, V.
Publicado 2022